Literature DB >> 24169492

5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.

Ryuhei Uchiyama1, Hisashi Uhara1, Aya Uchiyama1, Eisaku Ogawa1, Yuko Takazawa1, Atsuko Ashida1, Hiroshi Koga1, Koichi Hayashi1, Yukiko Kiniwa1, Ryuhei Okuyama2.   

Abstract

Entities:  

Keywords:  5-Hydroxymethylcytosine; Biomarker; Epigenetics; Melanoma

Mesh：

Substances：

Year:  2013        PMID： 24169492     DOI： 10.1016/j.jdermsci.2013.09.008

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  17 in total

Review 1.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

Review 2.  The role of 5-hydroxymethylcytosine in human cancer.

Authors:  Gerd P Pfeifer; Wenying Xiong; Maria A Hahn; Seung-Gi Jin
Journal:  Cell Tissue Res       Date:  2014-05-10       Impact factor: 5.249

3.  Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.

Authors:  Nemanja Rodić; John Zampella; Reema Sharma; Kathleen H Burns; Janis M Taube
Journal:  J Cutan Pathol       Date:  2015-09-02       Impact factor: 1.587

Review 4.  Melanoma epigenetics: novel mechanisms, markers, and medicines.

Authors:  Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Lab Invest       Date:  2014-06-30       Impact factor: 5.662

5.  5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.

Authors:  Gerald Saldanha; Kushal Joshi; Kathryn Lawes; Mark Bamford; Farhaan Moosa; Kah Wee Teo; J Howard Pringle
Journal:  Mod Pathol       Date:  2016-10-07       Impact factor: 7.842

6.  Identification of a melanoma susceptibility locus and somatic mutation in TET2.

Authors:  Fengju Song; Christopher I Amos; Jeffrey E Lee; Christine G Lian; Shenying Fang; Hongliang Liu; Stuart MacGregor; Mark M Iles; Matthew H Law; Neal I Lindeman; Grant W Montgomery; David L Duffy; Anne E Cust; Mark A Jenkins; David C Whiteman; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Kevin M Brown; Nicholas G Martin; Graham J Mann; D Timothy Bishop; Julia A Newton Bishop; Peter Kraft; Abrar A Qureshi; Peter A Kanetsky; Nicholas K Hayward; David J Hunter; Qingyi Wei; Jiali Han
Journal:  Carcinogenesis       Date:  2014-06-30       Impact factor: 4.944

7.  A nonsense nucleotide substitution in the oculocutaneous albinism II gene underlies the original pink-eyed dilution allele (Oca2(p)) in mice.

Authors:  Haruka Shoji; Yukiko Kiniwa; Ryuhei Okuyama; Mu Yang; Keiichi Higuchi; Masayuki Mori
Journal:  Exp Anim       Date:  2015-01-22

8.  5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.

Authors:  Santiago Uribe-Lewis; Rory Stark; Thomas Carroll; Mark J Dunning; Martin Bachman; Yoko Ito; Lovorka Stojic; Silvia Halim; Sarah L Vowler; Andy G Lynch; Benjamin Delatte; Eric J de Bony; Laurence Colin; Matthieu Defrance; Felix Krueger; Ana-Luisa Silva; Rogier Ten Hoopen; Ashraf Ek Ibrahim; François Fuks; Adele Murrell
Journal:  Genome Biol       Date:  2015-04-01       Impact factor: 13.583

9.  5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.

Authors:  Jonathan J Lee; Scott R Granter; Alvaro C Laga; Arturo P Saavedra; Qian Zhan; Weimin Guo; Shuyun Xu; George F Murphy; Christine G Lian
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

10.  Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.

Authors:  Jonathan J Lee; Lynette M Sholl; Neal I Lindeman; Scott R Granter; Alvaro C Laga; Priyanka Shivdasani; Gary Chin; Jason J Luke; Patrick A Ott; F Stephen Hodi; Martin C Mihm; Jennifer Y Lin; Andrew E Werchniak; Harley A Haynes; Nancy Bailey; Robert Liu; George F Murphy; Christine G Lian
Journal:  Clin Epigenetics       Date:  2015-06-09       Impact factor: 6.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.